Pro-neurotensin depends on renal function and is related to all-cause mortality in chronic kidney disease.

Abstract

BACKGROUND:

Patients with chronic kidney disease (CKD) have a high risk of premature cardiovascular diseases (CVD) and show increased mortality. Pro-neurotensin (Pro-NT) was associated with metabolic diseases and predicted incident CVD and mortality. However, Pro-NT regulation in CKD and its potential role linking CKD and mortality have not been investigated, so far.

METHODS:

In a central lab, circulating Pro-NT was quantified in three independent cohorts comprising 4715 participants (cohort 1: patients with CKD; cohort 2: general population study; and cohort 3: non-diabetic population study). Urinary Pro-NT was assessed in part of the patients from cohort 1. In a 4th independent cohort, serum Pro-NT was further related to mortality in patients with advanced CKD. Tissue-specific Nts expression was further investigated in two mouse models of diabetic CKD and compared to non-diabetic control mice.

RESULTS:

Pro-NT significantly increased with deteriorating renal function (P < 0.001). In meta-analysis of cohorts 1-3, Pro-NT was significantly and independently associated with estimated glomerular filtration rate (P ≤ 0.002). Patients in the middle/high Pro-NT tertiles at baseline had a higher all-cause mortality compared to the low Pro-NT tertile (Hazard ratio: 2.11, P = 0.046). Mice with severe diabetic CKD did not show increased Nts mRNA expression in different tissues compared to control animals.

CONCLUSIONS:

Circulating Pro-NT is associated with impaired renal function in independent cohorts comprising 4715 subjects and is related to all-cause mortality in patients with end-stage kidney disease. Our human and rodent data are in accordance with the hypotheses that Pro-NT is eliminated by the kidneys and could potentially contribute to increased mortality observed in patients with CKD.

• Authors: Anke Tönjes, Annett Hoffmann, Susan Kralisch, Abdul Rashid Qureshi, Nora Klöting, Markus Scholz, Dorit Schleinitz, Anette Bachmann, Jürgen Kratzsch, Marcin Nowicki, Sabine Paeschke, Kerstin Wirkner, Cornelia Enzenbach, Ronny Baber, Joachim Beige, Matthias Anders, Ingolf Bast, Matthias Blüher, Peter Kovacs, Markus Löffler, Ming-Zhi Zhang, Raymond C Harris, Peter Stenvinkel, Michael Stumvoll, Mathias Fasshauer, Thomas Ebert
• Journal: European journal of endocrinology (Eur J Endocrinol) Vol. 183 Issue 3 Pg. 233-244 (Sep 2020) ISSN: 1479-683X [Electronic] England
• PMID: 32508317 (Publication Type: Journal Article)

Chemical References

• Neurotensin

Topics

• Adult
• Aged
• Aged, 80 and over
• Animals
• Cross-Sectional Studies
• Female
• Glomerular Filtration Rate (physiology)
• Humans
• Kidney (metabolism, physiopathology)
• Longitudinal Studies
• Male
• Meta-Analysis as Topic
• Mice
• Middle Aged
• Neurotensin (blood, metabolism)
• Renal Insufficiency, Chronic (blood, metabolism, mortality, physiopathology)